The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis

被引:227
作者
Fuss, IJ
Boirivant, M
Lacy, B
Strober, W
机构
[1] NIAID, Mucosal Immun Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
[2] Ist Super Sanita, Immunol Lab, I-00161 Rome, Italy
关键词
D O I
10.4049/jimmunol.168.2.900
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the present study, we define the relation between TGF-beta and IL-10 in the regulation of the Th1-mediated inflammation occurring in trinitrobenzene sulfonic acid (TNBS)-colitis. In initial studies, we showed that the feeding of trinitrophenol-haptenated colonic protein to SJL/J mice induces CD4(+) regulatory T cells that transfer protection from induction of TNBS-colitis, and that such protection correlates with cells producing TGF-beta, not IL-10. Further studies in which SJL/J mice were fed haptenated colonic protein, and then administered either anti-TGF-beta or anti-IL-10 at the time of subsequent TNBS administration per rectum, showed that while both Abs abolished protection, anti-TGF-beta administration prevented TGF-beta secretion, but left IL-10 secretion intact; whereas anti-IL-10 administration prevented both TGF-beta secretion and IL-10 secretion. Thus, it appeared that the protective effect of IL-10 was an indirect consequence of its effect on TGF-beta secretion. To establish this point further, we conducted adoptive transfer studies and showed that anti-IL-10 administration had no effect on induction of TGF-beta producing T cells in donor mice. However, it did inhibit their subsequent expansion in recipient mice, probably by regulating the magnitude of the Th1 T cell response which would otherwise inhibit the TGF-beta response. Therefore, these studies suggest that TGF-beta production is a primary mechanism of counter-regulation of Th1 T cell-mediated mucosal inflammation, and that IL-10 is necessary as a secondary factor that facilitates TGF-beta production.
引用
收藏
页码:900 / 908
页数:9
相关论文
共 26 条
[1]  
Agace WW, 2000, EUR J IMMUNOL, V30, P819, DOI 10.1002/1521-4141(200003)30:3<819::AID-IMMU819>3.3.CO
[2]  
2-P
[3]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[4]   Regulation of TGF-β response during T cell activation is modulated by IL-10 [J].
Cottrez, F ;
Groux, H .
JOURNAL OF IMMUNOLOGY, 2001, 167 (02) :773-778
[5]   Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis [J].
Cua, DJ ;
Groux, H ;
Hinton, DR ;
Stohlman, SA ;
Coffman, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) :1005-1010
[6]  
DING L, 1992, J IMMUNOL, V148, P3133
[7]   Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation [J].
Ebert, LM ;
McColl, SR .
JOURNAL OF IMMUNOLOGY, 2001, 166 (08) :4870-4878
[8]  
Groux H, 1999, J IMMUNOL, V162, P1723
[9]   A CD4(+) T-cell subset inhibits antigen-specific T-cell responses and prevents colitis [J].
Groux, H ;
OGarra, A ;
Bigler, M ;
Rouleau, M ;
Antonenko, S ;
deVries, JE ;
Roncarolo, MG .
NATURE, 1997, 389 (6652) :737-742
[10]   Regulatory T cells and inflammatory bowel disease [J].
Groux, H ;
Powrie, F .
IMMUNOLOGY TODAY, 1999, 20 (10) :442-446